| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Cost of Revenue | $555K | — |
| Gross Profit | -$555K | — |
| R&D Expense | $16.8M | +42.4% |
| SG&A Expense | $34.7M | +88.5% |
| Operating Income | -$52.1M | -27.9% |
| Interest Expense | $30K | -96.1% |
| Pre-tax Income | -$59.4M | -34.8% |
| Net Income | -$55.8M | -29.3% |
| EPS (Basic) | -$1.86 |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $29.2M | -63.7% |
| Short-term Investments | $16.7M | — |
| Accounts Receivable | $420K | +30.4% |
| Inventory | $1.1M | +222.6% |
| Current Assets | $59.4M | -36.1% |
| Total Assets | $68.7M | -30.7% |
| Current Liabilities | $19.8M | +84.7% |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$33.0M | -42.7% |
| Capital Expenditures | $3.9M | +180.9% |
| Investing Cash Flow | -$20.6M | -1319.8% |
| Financing Cash Flow | $2.7M | -96.6% |
| Free Cash Flow | -$36.9M | -50.5% |
| -10.7% |
| Long-term Debt |
| $200K |
| +0.0% |
| Total Liabilities | $26.7M | +27.3% |
| Stockholders' Equity | $37.9M | -47.9% |